The North Carolina State Health Plan provides a striking example of the financial implications involved, estimating that continuing to cover brand GLP-1s for weight loss in 2024 would require increasing premiums by $48.50 per subscriber per month for all members, not just GLP-1 users
In clinical trials, retatrutide has been administered via subcutaneous injection on a once-weekly basis, with doses escalating gradually over several weeks to improve tolerability
This clearance mechanism has also been described in the context of different cellular stressors leading to PS exposure, e.g., hyperosmotic stress [217], plasmodium infection [77], oxidative stress [72], and, to some extent, also ageing of erythrocytes [218]
Notify your provider of any unusual or severe symptoms
Prescribing thresholds may differ in other countries
One question that arises for some people taking semaglutide is whether it can cause frequent urination, also known as polyuria